Intragastric implants with duodenal anchors

• US 9,668,901 B2
• Filed: 07/09/2013
• Issued: 06/06/2017
• Est. Priority Date: 10/18/2010
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Apollo Endosurgery US, Inc. (Boston Scientific Corporation)
• Inventors: Babkes, Mitchell H., Raven, Joseph, Dominguez, Zachary
• Primary Examiner(s): Zalukaeva, Tatyana
• Assistant Examiner(s): SASS, SARA A
• Application Number:
  US13/938,010
• Publication Number:
  US 20130296765A1
• Time in Patent Office: 1,428 Days
• CPC Class Codes: A61F 5/0033 with more than one chamber
• CPC Class Codes: A61F 5/0036 Intragastrical devices
• CPC Class Codes: A61F 5/0079 Pyloric or esophageal obstructions

Abstract

Intragastric fluid transfer devices and related methods for operation thereof are disclosed. The intragastric fluid transfer devices and related methods are intended to assist a patient in maintaining a healthy body weight by stimulating the inner stomach walls and/or the inner duodenum walls. Features of the intragastric fluid transfer device include insertion of the devices transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these intragastric fluid transfer devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer.

Claims

1. An implantable device configured to be placed in a patient'"'"'s stomach and duodenum region transorally without surgery to treat and prevent obesity, comprising:

an inflatable gastric balloon defining an inflatable space and residing in the patient'"'"'s stomach and formed of a material that can withstand the acidic environment of the patient'"'"'s stomach for at least 6 months, the gastric balloon having an inflated volume sufficient to ensure that the gastric balloon cannot pass through patient'"'"'s pylorus;

an inflatable intra-duodenal balloon defining an inflatable space and having a deflated volume that will fit within the patient'"'"'s duodenum and allow food to pass and an inflated volume that contacts the walls of the duodenum;

a fluid transfer conduit coupled between the inflatable space of the gastric balloon and the inflatable space of the intra-duodenal balloon; and

a first valve located between, and in fluid communication with, the inflatable space of the gastric balloon and the inflatable space of the intra-duodenal balloon, the first valve configured to allow fluid to flow freely from the inflatable space of the gastric balloon to the fluid transfer conduit and limit backflow of fluid from the fluid transfer conduit to the inflatable space of the gastric balloon.

2. The device of claim 1, wherein the first valve is a duckbill valve.

3. The device of claim 1, wherein the first valve is configured to limit backflow back into the gastric balloon to 0.2 cubic centimeters per hour.

4. The device of claim 1, further comprising a flow restrictor located between the gastric balloon and intra-duodenal balloon, the second valve configured to allow fluid to flow from the intra-duodenal balloon to the gastric balloon only when the pressure within the intra-duodenal balloon exceeds the pressure within the gastric balloon.

5. The device of claim 1, wherein the flow restrictor limits flow back into the gastric balloon to a flow rate of between 0.1 μ

L per hour to about 1 L per hour.

6. The device of claim 1, wherein the gastric balloon is configured to maintain a volume of 200 milliliters or more to prevent the gastric balloon from migrating into a pylorus region of the patient.

7. The device of claim 1, wherein the gastric balloon has an uneven surface feature that provides stimulation to the stomach walls.

8. A passive intragastric obesity treatment implant, comprising:

a series of inflatable members connected together with intermediate tethers, each of the inflatable members having slots or flutes on their external surfaces, the inflatable members each having a size that will not pass through the pyloric sphincter and together taking up volume within the stomach of at least 400 ml and being made of a material that will resist degradation over a period of at least six months within the stomach; and

a duodenal anchor connected to a distal inflatable member with a distal tether, the duodenal anchor having a size that permits it to pass through the pyloric sphincter and be formed of a material of sufficient mass and specific gravity that prevents it from migrating back up through the pyloric sphincter.

9. The implant of claim 8, wherein a proximal inflatable member includes an internally threaded sleeve suitable for receiving an externally threaded end of a delivery tube.

10. The implant of claim 8, wherein the intermediate tethers are tubular permitting passage of a stiff rod through the series of inflatable members.

11. The implant of claim 8, wherein the distal tether includes a heat formed distal end and a second heat formed bead just proximal to a steel ball to retain the steel ball thereon.

12. A passive intragastric obesity treatment implant, comprising:

an expandable frame formed of a plurality of longitudinally extending struts, the struts being circumferentially spaced apart on a common circumference, and the frame having an expanded diameter sufficient to prevent passage through the pyloric sphincter;

a tether connected to a distal end of the frame; and

a duodenal anchor connected to one end of the tether, the duodenal anchor having a size that permits it to pass through the pyloric sphincter and be formed of a material of sufficient mass and specific gravity that prevents it from migrating back up through the pyloric sphincter,

the implant being formed of a material which permits it to be compressed into a substantially linear delivery configuration and that will resist degradation over a period of at least six months within the stomach.

13. The implant of claim 12, wherein the frame in its expanded state has an oblong shape.

14. The implant of claim 12, wherein the duodenal anchor comprises a stainless steel ball.

15. The implant of claim 12, wherein the frame has a hollow threaded proximal end to which an obturator may attach for delivering and removing the frame.

19. The implant of claim 12, wherein the struts define a plurality of longitudinally extending openings in the frame between the struts.

20. The implant of claim 12, wherein the struts are discrete, elongated members.

16. A passive intragastric obesity treatment implant, comprising:

an inflatable member having an inflated size sufficient to occupy space within the stomach and preventing passage down the pylorus or back up through the esophageal sphincter;

a ribbed duodenal sleeve for positioning in the duodenum and being reinforced to prevent kinking, wherein the duodenal sleeve comprises a flexible sleeve wall reinforced by a plurality of longitudinally spaced loops, wherein the longitudinal spacing between adjacent loops is less than a diameter of the loops; and

a tether attaching the duodenal sleeve to the inflatable member, the implant being formed of a material which permits it to be compressed into a substantially linear delivery configuration and that will resist degradation over a period of at least six months within the stomach.

17. The implant of claim 16, wherein the inflatable member further includes a valve member for filling and emptying the member with a fluid.

18. The implant of claim 16, wherein the tether comprises a strong inner member coated with a material that resists degradation in the stomach.